Navigation Links
Austen BioInnovation Institute's Accountable Care Community initiative gains national support
Date:9/27/2011

WASHINGTON, September 27, 2011 - The Austen BioInnovation Institute in Akron (ABIA), its founding members and several community partners are the recipients of a national $500,000 award to fund the Accountable Care Community (ACC) initiative, the U.S. Department of Health and Human Services (HHS) announced today. ACC is a collective effort aiming to create a healthier community and lessen the burden of disease in the Akron region. The funding is part of a multimillion dollar CDC Community Transformation Program that supports public health efforts to reduce chronic diseases, promote healthier lifestyles, reduce health disparities, and control health care spending.

ABIA -- an unique collaboration of Akron Children's Hospital, Akron General Health System, Northeast Ohio Medical University, Summa Health System, The University of Akron and John S. and James L. Knight Foundation -- is the lead institution on the community grant and will collaborate with all of its founding members on the effort along with community partners, including Summit County Health District and Community Legal Aid Services. The ACC effort, focused on improving the community's health status and health care delivery while lessening the burden of disease, was launched at a national summit held in Akron in June.

"Through our collective efforts, we continue to establish Akron as an epicenter for patient-centered innovation and commercialization. Once again, we are receiving national recognition and support for the transformational power of our community's shared vision to create a healthier and more competitive region," said Dr. Frank L. Douglas, ABIA president and chief executive officer. "The work of this initiative, and that of our founding members, is moving us to improve lives and the productivity of our community."

The project is striving to focus all Akron-area public, private and philanthropic resources toward achieving improvements in population health and to
'/>"/>

Contact: Scott Rainone
srainone@abiakron.org
330-572-7581
Austen BioInnovation Institute in Akron
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Avoiding Dairy Due to Lactose Intolerance is Unnecessary in Most Cases and May Pose Diet and Health Risks, Concludes National Institutes of Health Consensus Development Conference Panel
2. GlobalSign to Demonstrate Online Security Solutions to Educational Institutes at NERCOMP Conference
3. CoreObjects Receives Project Management Institutes Excellence Award for Diabetes Contribution
4. National Institutes of Health Awards Kitware Over $600,000 to Develop Advancements in Neurosurgical Simulation
5. National Institutes of Health subscribes to OpenHelix training portal
6. UCSD cardiologist receives National Institutes of Health New Innovator Award
7. National Institutes of Health awards $1.2 million to GSU for collaborative study on discharge decisions at hospitals
8. Accountable care organizations have potential to curb costs and improve health care
9. Burden of HIV/TB infections increasingly falling on Hispanic community
10. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
11. What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... San Diego, CA (PRWEB) September 02, 2014 ... guide titled, “Is Group Therapy Right for Me?” The ... joining group therapy or counseling, in addition to common ... in group therapy improve not only from the interventions ... the group and receiving feedback from group members,” says ...
(Date:9/2/2014)... 2014 Friendship Village of Schaumburg ... “This creates a contemporary marketing presence and visually ... parent organization, Friendship Senior Options,” said Stephen A. ... “By changing the logo, we are making sure ... seniors and their families.” , Friendship Village is ...
(Date:9/2/2014)... Complications are rare among breast cancer patients who ... However, the researchers did find that a ... risk for certain complications than a single mastectomy. ... cancer patients who had a single (64 percent) ... were followed for 30 days after surgery. ...
(Date:9/2/2014)... WASHINGTON Patients who return to the emergency department within ... are anxious about their symptoms and have lost trust in ... results of a study published online today in Annals ... Department: The Patient Perspective" ). , "When asked ... reported feeling that their symptoms were too severe to wait ...
(Date:9/2/2014)... -- Two new studies further confirm the health benefits ... breast-fed have a lower risk of ear, throat and ... finds a similar trend when it comes to allergies. ... in the immediate newborn period," said Dr. Jennifer Wu, ... City. She was not involved in the new studies. ...
Breaking Medicine News(10 mins):Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... BALTIMORE, June 16 Lupin Pharmaceuticals, Inc. (LPI),announced ... the Company,s,Abbreviated New Drug Application (ANDA) for Escitalopram ... U.S. Food and Drug Administration (USFDA)., Lupin,s ... Laboratories, Lexapro(R) tablets, indicated for the treatment of,major ...
... Researchers at Ben-Gurion University of the Negev (BGU) in ... tested at a Washington, D.C. hospital, that enables doctors ... instead of touching a screen, keyboard or mouse which ... just released article. , The June article," A Gesture-based ...
... to injury-related deaths, the gap between black and white ... researchers at the Johns Hopkins Bloomberg School of Public ... injury-related deaths among blacks ages 15 to 24 decreased, ... published in the June, 2008, edition of Injury ...
... and PLM Based on Dassault Systemes, Newly,Introduced V6 Platform and ... ... ST. PAUL, Minnesota, June 16 Intercim LLC, a global,leader ... highly regulated industries and Dassault,Systemes (DS) (Nasdaq: DASTY; Euronext Paris: ...
... COLUMBIA, S.C., June 16 BlueCross BlueShield,of South ... of,the company,s health insurance plans that also adds ... options., "With increasing health care costs forcing ... dropping their insurance or not,picking it up to ...
... Coffee,s aroma kick-starts genes in the brain, Journal of ... a wake-up call to the brain? Or just smell its ... some of the first evidence that simply inhaling coffee aroma ... with laboratory rats, they found that coffee aroma orchestrates the ...
Cached Medicine News:Health News:Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets 2Health News:Gesture interface device developed by Ben-Gurion University of the Negev 2Health News:Racial disparities reduced in injury related mortality 2Health News:Intercim and Dassault Systemes Sign Memorandum of Understanding 2Health News:Intercim and Dassault Systemes Sign Memorandum of Understanding 3Health News:S.C. BlueCross Launches Less-Costly Plans Geared to Groups Seeking More Options 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 3Health News:American Chemical Society's Weekly PressPac: June 11, 2008 4Health News:American Chemical Society's Weekly PressPac: June 11, 2008 5Health News:American Chemical Society's Weekly PressPac: June 11, 2008 6Health News:American Chemical Society's Weekly PressPac: June 11, 2008 7Health News:American Chemical Society's Weekly PressPac: June 11, 2008 8
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that ... its catalogue: Acute Heart Failure Global ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart Failure ... Summary GlobalData,s clinical trial report, "Acute Heart ... data on the Acute Heart Failure clinical trial ...
(Date:9/2/2014)... ALBANY, New York , September 2, 2014 ... market report published by Transparency Market Research "Latin ... and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility ... Telehealth and Telemedicine, Respiratory Therapy, Infusion Therapy and ... Share, Growth, Trends and Forecast, 2014 - 2020" ...
(Date:9/2/2014)... España, September 2, 2014 ... fibrilación atrial muestran agentes antitrombóticos no utilizados óptimamente ... -- Las presentaciones de GARFIELD-AF en el ... tratamiento y los resultados de pacientes en riesgo ... --    Los datos de casi ...
Breaking Medicine Technology:Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11
... PediaVision today announced that Loma Linda University,s Vision ... of California to receive the revolutionary new vision ... of Ophthalmology is offering free vision screenings to ... of First 5 Riverside , which invests ...
... DURHAM, N.C., Sept. 29, 2011 CoLucid Pharmaceuticals, Inc., ... Chief Executive Officer, Thomas P. Mathers, will be making ... Conference at 9:35 – 10:00 a.m. on Tuesday, October ... Hotel in Tokyo, Japan. The partnering meeting is expected ...
Cached Medicine Technology:Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 2Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 3Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 4CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: